🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in the Netherlands / NCT05987579
Active, not recruiting Observational

Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp

NCT05987579 · tracked via the Priya Life Science Netherlands tracker
Phase
Observational
Started
2021-05-03
Last updated
2025-04-04

Condition(s) studied

Squamous Cell CarcinomaSurgeryCancer Head Neck

Study summary

This study examines tumor- en surgical characteristics of stage T3 cutaneous squamous cell carcinomas on the scalp, diagnosed between 2010 and 2018. Histological data and patient- and tumor characteristics were collected.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * stage T3 cutaneous squamous cell carcinoma of the scalp (histologically proven) * surgical treatment or radiotherapy treatment Exclusion Criteria: * metastasis by diagnosis * stage T1/T2/T4

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Ellen Oyen Maastricht Netherlands

More Maastricht University Medical Center trials in the Netherlands

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05987579 on ClinicalTrials.gov ↗ ← All trials in the Netherlands